Robert Routs - Koninklijke DSM Chairman of the Supervisory Board
| KDSKF Stock | USD 43.02 65.78 60.46% |
Chairman
Dr. Robert J. Routs has served as Independent Chairman of the Supervisory Board of Royal DSM NV since April 28, 2011. He was first appointed to the Supervisory Board, as Member, on March 31, 2010. He is Member of the Company Remuneration Committee and Chairman of the Company Nominating Committee. In his professional career he also was appointed Executive Director Downstream and Member of the Board of Royal Dutch Shell plc., as well as Member Board of Directors of AECOM, ATCO Group Ltd. and The Drilling Company of 1972 AS since 2011.
| Age | 71 |
| Tenure | 13 years |
| Professional Marks | Ph.D |
| Phone | 31 45 578 8111 |
| Web | https://www.dsm.com |
Koninklijke DSM Management Efficiency
The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 10 records | CHAIRMAN Age | ||
| John Morikis | Sherwin Williams Co | 61 | |
| Christopher Connor | Sherwin Williams Co | 58 | |
| Seifollah Ghasemi | Air Products and | 80 | |
| Benoit Potier | Air Liquide SA | 59 | |
| Douglas Baker | Ecolab Inc | 62 | |
| Charles Bunch | PPG Industries | 65 | |
| Edward Breen | Dupont De Nemours | 68 | |
| Tony Caktiong | Dupont De Nemours | 64 | |
| Douglas Ford | Air Products and | 69 | |
| Edgar Sia | Dupont De Nemours | N/A | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 |
Koninklijke DSM NV Leadership Team
Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Routs, Chairman of the Supervisory Board | ||
| Eileen Kennedy, Member of the Supervisory Board | ||
| Ewald Kist, Deputy Chairman of the Supervisory Board | ||
| Frits Paasschen, Independent Member of the Supervisory Board | ||
| John Ramsay, Independent Member of the Supervisory Board | ||
| Stefan Doboczky, Member of the Managing Board | ||
| Paul Gilgen, Head Products | ||
| Lieke JongTops, Communications Mang | ||
| Stephan Tanda, Member of the Managing Board | ||
| Geraldine Matchett, CFO and Member of the Managing Board | ||
| Luca Rosetto, VP Products | ||
| Dimitri Vreeze, Member of the Managing Board | ||
| Dave Huizing, Vice President Investor Relations | ||
| Rob Atsma, Head Nederland | ||
| Pauline Mohr, Member of the Supervisory Board | ||
| Victoria Haynes, Member of the Supervisory Board | ||
| Jan Wolters, Head Chemicals | ||
| Bruno Mller, Head Products | ||
| Pradeep Pant, Member of the Supervisory Board | ||
| Manfred Eggersdorfer, VP Advocacy | ||
| Feike Sijbesma, Chairman of the Managing Board and CEO | ||
| Pierre Hochuli, Member of the Supervisory Board | ||
| Tom Swaan, Member of the Supervisory Board |
Koninklijke Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Koninklijke DSM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 23.38 B | |||
| Shares Outstanding | 172.97 M | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 56.99 % | |||
| Price To Earning | 37.75 X | |||
| Price To Book | 2.12 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Koninklijke DSM in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Koninklijke DSM's short interest history, or implied volatility extrapolated from Koninklijke DSM options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Koninklijke DSM NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Koninklijke Pink Sheet analysis
When running Koninklijke DSM's price analysis, check to measure Koninklijke DSM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Koninklijke DSM is operating at the current time. Most of Koninklijke DSM's value examination focuses on studying past and present price action to predict the probability of Koninklijke DSM's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Koninklijke DSM's price. Additionally, you may evaluate how the addition of Koninklijke DSM to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |